Keywords: Biomarkers, Quantitative Imaging, Cancer; Molecular Imaging; Brain
Motivation: The aggressiveness of glioma depends on IDH mutation type, classification of which requires genetic analysis following a biopsy. This is an invasive procedure which can have lengthy wait times to receive results.
Goal(s): Explore quantitative T1ρ imaging as a noninvasive biomarker for IDH1 mutation typing in a glioma mouse model.
Approach: Mice with were implanted with IDH1-wildtype and IDH1-mutant glioma tumours and imaged weekly for five weeks with T1ρ and CEST as tumours developed.
Results: T1ρ can distinguish IDH1-mutant glioma from healthy brain tissue, whereas T1ρ values of IDH1-wildtype tumors are not significantly different from healthy brain.
Impact: T1ρ quantitative imaging shows promise as a noninvasive biomarker to determine IDH1 mutation status in glioma. Such a biomarker would allow faster classification, eliminating the wait time for biopsy results and potentially improving patient outcome through more personalized treatment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords